FDA Approved Products

4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: LOE ApproachingClear all
FURADANTIN
nitrofurantoin
LOE Approaching
R-Pharm US
ORAL · SUSPENSION
pyelonephritisperinephric abscesses+1
1953
NDA
30/100
FURADANTIN
nitrofurantoin
LOE Approaching
ORAL · TABLET
1953
NDA
30/100
FUROSEMIDE
furosemide
LOE Approaching
Fresenius Kabi
INJECTION · INJECTABLE
edema associated with heart failurecirrhosis of the liver+3
1984
NDA
30/100
FUROSEMIDE
furosemide
LOE Approaching
Hikma
INJECTION · INJECTABLE
cirrhosis of the liverrenal disease+1
1981
NDA
30/100
FUROSEMIDE
furosemide
LOE Approaching
Pfizer
INJECTION · INJECTABLE
edema associated with heart failurecirrhosis of the liver+3
1982
NDA
30/100
FUROSEMIDE
furosemide
LOE Approaching
ORAL · TABLET
1994
NDA
30/100
FUROSEMIDE
furosemide
LOE Approaching
ORAL · TABLET
1982
NDA
30/100
FUROSEMIDE
furosemide
LOE Approaching
Medica Corp
INJECTION · INJECTABLE
1979
NDA
30/100
FUROSEMIDE
furosemide
LOE Approaching
PharmaIN
ORAL · TABLET
1983
NDA
30/100
FUROSEMIDE
furosemide
LOE Approaching
Medica Corp
ORAL · TABLET
1984
NDA
30/100
FUROSEMIDE
furosemide
LOE Approaching
INJECTION · INJECTABLE
1983
NDA
30/100
FUROSEMIDE
furosemide
LOE Approaching
ORAL · TABLET
1981
NDA
30/100
FUROSEMIDE
furosemide
LOE Approaching
Teva
ORAL · TABLET
1982
NDA
30/100
FUROSEMIDE
furosemide
LOE Approaching
ORAL · TABLET
cirrhosis of the liverrenal disease+2
1981
NDA
30/100
FUROSEMIDE
furosemide
LOE Approaching
Molecular Devices
ORAL · TABLET
cirrhosis of the liverrenal disease+2
1983
NDA
30/100
FUROSEMIDE
furosemide
LOE Approaching
Hikma
ORAL · TABLET
cirrhosis of the liverrenal disease+2
1983
NDA
30/100
FUROXONE
furazolidone
LOE Approaching
Takeda
ORAL · SUSPENSION
1958
NDA
30/100
FUROXONE
furazolidone
LOE Approaching
Takeda
ORAL · TABLET
1961
NDA
30/100
FUSILEV
levoleucovorin calcium
LOE Approaching
Acrotech Biopharma
INTRAVENOUS · SOLUTION
2008
NDA
30/100
FUZEON
enfuvirtide
LOE Approaching
Roche
SUBCUTANEOUS · INJECTABLE
2003
PeptideNDA
30/100
GABITRIL
tiagabine hydrochloride
LOE Approaching
Teva
ORAL · TABLET
1997
NDA
30/100
GABLOFEN
baclofen injection
LOE Approaching
INTRATHECAL · INJECTABLE
2010
NDA
30/100
GADAVIST
gadobutrol
LOE Approaching
Bayer
INTRAVENOUS · SOLUTION
Gadolinium-based Contrast Agent
2011
NDA
30/100
GALLIUM CITRATE GA 67
gallium citrate ga-67
LOE Approaching
Lantheus Medical Imaging
INJECTION · INJECTABLE
1976
NDA
30/100
← PreviousPage 67 of 188Next →